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Summary. A total of 81 patients with symptomatic blad- 
der-outlet obstruction (BOO) due to benign prostatic hyper­
plasia (BPH) underwent visual laser ablation of the prostate 
(VLAP) using a right-angled firing neodynium: YAG laser. 
The mean pre-operative prostatic volume was 48.5 ml. All 
patients were discharged on the 1st post-operative day with 
an indwelling catheter. Two patients underwent a trans­
urethral prostatectomy (TURP) after failing a trial without 
catheter on two occasions. Of the remaining 79 patients, 
75 were evaluated 6 months post-operatively. Mean symp­
tom scores (I-PSS) decreased from 20,9 to 5.8, the mean 
maximal urinary flow rate increased from 7.9 to 16.4 ml/s 
and the mean residual volume decreased from 88.1 to 15.6 
ml. Several different methods of evaluating BOO from 
pressure-flow measurements were used and all showed im­
provement. All the above-mentioned parameters showed a 
highly significant improvement (P <0.01) at 6 months.
Transurethral resection of the prostate (TURP) is cur­
rently the optimal treatment for patients with lower-uri- 
nary-tract symptoms and proven bladder-outlet obstruction 
(BOO) secondary to benign prostatic hyperplasia (BPH). 
However, it has a significant morbidity and mortality [4, 
10] and up to a quarter of patients have a less than satis­
factory outcome [11, 17]. There is therefore scope for 
safer and more effective methods of treatment of BPH.
Visual laser ablation of the prostate (VLAP) is being 
rapidly introduced as a new treatment for BOO due to 
BPH but needs proper evaluation prior to its widespread 
use. Although short-term studies are encouraging, enabling 
a short in-patient stay and low peri-operative blood loss 
[3,7, 9], the long-term results are not yet known. It is well 
documented that patients found to be obstructed on pres­
sure-flow studies do better after TURP than unobstructed 
patients [12]. As laser prostatectomy aims to remove ob­
structing pro static tissue in a manner similar to that of 
TURP, this study aimed to evaluate the objective outcome 
of VLAP using pressure-flow studies.
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Patients and methods
Between December 1992 and December 1993, 81 patients under­
going VLAP in 2 European centres were studied. All patients 
were over 50 years of age and considered suitable for elective 
prostatectomy. The prostatic volume was measured pre-opera- 
tively by transrectal ultrasound. VLAP was performed using a 
neodynium: YAG laser with right-angled laser fibre (Urolase or 
Ultraline), For the Urolase fiber a 40-W power setting with con­
tinuous firing for 60-90 s to four quadrants was used. The Ultra- 
line fiber was used in a 60-W power setting with “painting” of the 
prostate. Laser energy was applied for a total of 90 s to four quad­
rants. Post-operatively, 20 patients underwent transurethral cathe- 
terisation and 61 patients underwent suprapubic catheterisation. 
All patients were discharged on the 1st post-operative day. The 
group with urethral catheters underwent a trial without catheter 
7-10 days later, but the suprapubic group kept their catheters un­
til they were voiding satisfactorily with a small post-void residual 
urinary volume (mean, 18 days).
All patients underwent subjective assessment pre-operatively 
and 6 months post-operatively with the International Prostate 
Symptom Score (I-PSS) questionnaire. This comprises 7 questions 
with a maximal score of 5 per question, depending on the severity 
of the urinary symptoms; thus, a maximal total score of 35 is pos­
sible for the most severe symptoms.
Objective assessment pre-operatively and 6 months post-oper­
atively included measurement of maximal urinary flow rates and 
residual urinary volume by ultrasound and pressure-flow studies. 
Pressure-flow studies were performed using a rectal and a urethral 
catheter. Filling of the bladder through the urethral line was per­
formed with the patient in the lying or standing position, and void­
ing was done in the standing position. From the recordings the 
maximal flow rate (Qmax) and detrusor pressure at maximal flow 
(Pdet Qmax) were noted. The degree of bladder-outlet obstruction 
was evaluated using the Abrams-Griffiths (AG) nomogram [1], 
Griffiths’ urethral resistance factor (URA) [5], the parameters 
from passive urethral resistance relation (PURR) analysis [13] 
A thco (theoretical cross-sectional area of the urethra during void­
ing) and Pmuo (minimal detrusor pressure with ongoing flow), 
Schafer’s grade of obstruction (LPURR) [14], and the AG number 
[8] (Pdet Qmax-2Qmax). Statistical analysis was performed using 
the Wilcoxon matched-pairs signed-rank test. .
Results
Of the original 81 patients, 2 underwent a TURP follow­
ing 2 failed trials without catheter. Both of these patients 
were in the group that received urethral catheters post-op-
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Table 1. Pre-operative characteristics
Total number of patients 75
Mean age 65.3 ± 6.7 years
Mean prostatic volume 48.5 ± 17.2 ml
Mean in-patient stay 2 days
Trial without catheter 7-18 days
Laser used Side-firing Nd : Y AG
eratively. One patient refused follow-up pressure-flow 
studies at 6 months, although symptomatically he was 
much improved, and the pressure-flow data were inade­
quate for analysis in three patients. Thus, 75 patients were 
further analysed 6 months post-operatively. Their charac­
teristics and treatment are shown in Table 1.
Pre- and post-operative symptom scores and urody- 
namic measurements are shown in Table 2. The mean val­
ues for each of the seven pre-operative IPSS questions 
were found to decrease significantly post-operatively. 
Free maximal urinary flow rates (Qmax) and mean post­
void residual urinary volume (PVR), measured using ul­
trasound, improved significantly (P < 0.01). During pres- 
sure-flow studies the maximal cystometric capacity (MCC),
maximal urinary flow rate (QmaxPF), and detrusor pres­
sure at maximal flow (PdctQmax) improved significantly 
when pre- and post-operative values were compared (P < 
0.01).
The results of the other methods of assessing outlet ob­
struction pre- and post-operatively are summarised in 
Table 3. All showed a statistically significant improve­
ment (P < 0.01).
Figure 1 shows the results of all 75 patients plotted 
onto the AG nomogram. This shows a general trend from 
the obstructed region pre-operatively towards the unob­
structed region post-operatively, although some patients 
remain obstructed. For comparison of the urodynamic 
changes found after VLAP with those seen in patients 
who were treated with TURP in a non-randomised fashion, 
a comparable number of patients from Bristol were evalu­
ated before and after TURP (Fig.2). This shows a similar 
shift towards the unobstructed region post-operatively.
Discussion
Although previous studies [3,7, 9] have shown good sub­
jective outcomes following VLAP, the objective assess­
ments have relied on uroflowmetry. Previous studies have
Table 2. Pre- and post-operative symptom scores and urodynamic data: mean values and standard deviations
Weeks I-PSS Qmax (ml/s) PVR (ml) MCC (ml) QmaxPF (ml/s) Pde,Qmax (cmH20)
0 20.9 ± 5.8 7.9 ± 2.9 88.1 ± 87.9 195.8 ± 103,8 6.0 ± 2.8 79.8 ± 28.4
26 5.8 ± 4.4 16.4 ± 5.8 15.6 ± 31.7 338.2 ± 155.1 13.7 ± 5.6 40.1 ± 20.3
Table 3. Pre- and post-operative measure­
ments of outlet obstruction: mean values 
and range of results
Weeks UR A 
(cm H20)
LPURR Ajheo
(mm2)
pmuo
(cm H20)
AG number
0 49.5 3.7 2.25 42.2 68.0
(23.0-113.0) (1.0-6.0) (0.5-5. Í) (12-100) (21.4-144.6)
26 18.8 1.1 7.5 17.6 10.9
(6.0-56.2) (0-5.0) (2.0-18.1) (0-50) (-44.0—flO  1.0)
Qmax (ml/s)
Fig. 1. Abrams-Griffiths nomogram of pre- and post-operative 
pressure versus flow values of patients undergoing VLAP; #  base­
line; A 6 months
Qmax (ml/s)
Fig. 2. Abrams-Griffiths nomogram of pre- and post-operative 
pressure versus flow values of patients undergoing TURP; •  base­
line; A 6 months
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questioned the reliability of uroflowmetry alone in the di­
agnosis of outlet obstruction. Schafer et al. [15] found that 
only 74% of patients classified as obstructed on uroflow­
metry were also obstructed on pressure-flow studies, and 
Chancellor et al. [2] concluded that bladder-outlet ob­
struction and detrusor underactivity could not be distin­
guished on the basis of uroflowmetry. The uroflowmetry 
parameters are associated with obstructive voiding, not 
with the grade of obstruction. Pressure-flow studies are 
therefore essential in the objective assessment of any new 
treatment aimed at relieving outlet obstruction.
Studies evaluating urodynamic changes in pressure- 
flow parameters in alternative BPH treatments are sparse. 
The available data suggest minimal urodynamic changes 
incomparable with results seen after TURP [6, 16]. The 
results of the present study suggest that VLAP is an effec­
tive method in the treatment of bladder-outlet obstruction 
as determined by pressure-flow studies. Figures 1 and 2 
show there is little difference between the improvement 
seen with the “gold standard” TURP and that experienced 
by the VLAP study. However, the ability of VLAP to re­
lieve obstruction as compared with TURP can be deter­
mined only in a randomised prospective manner.
The majority of the patients in the present study were 
urodynamically obstructed pre-operatively. The small 
group of non-obstructed patients were also successfully 
treated with laser treatment, showing both good sympto­
matic and good objective improvement. However, for 
these patients, other less invasive therapies, e.g. medical 
treatment or thermotherapy, should be considered.
Long-term subjective and objective follow-up as well 
as comparative studies with conventional therapy are nec­
essary for adequate assessment of this new technique. The 
results of large multicentre trials, currently under way, 
comparing TURP with VLAP and “watchful waiting” are 
awaited.
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